JILL BUECHE: Open Payments
NPI 1598370991 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 13 payments from 9 companies in 2025. Trend: 2023 $397 · 2024 $334 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $61 |
| Exact Sciences Corporation | 3 | $54 |
| ABBVIE INC. | 2 | $36 |
| BioMarin Pharmaceutical Inc. | 1 | $30 |
| Ardelyx, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $25 |
| Krystal Biotech Inc | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| PFIZER INC. | 1 | $14 |
Products named: INGREZZA, The Cologuard Plus Collection Kit, VRAYLAR, VOXZOGO 1.2mg, IBSRELA, FREESTYLE LIBRE, VYJUVEK, MOUNJARO.
Industry payments across LA — which companies pay providers there.
